Cerebral edema in brain cancer: Difference between revisions
(Created page with "==Background== *Classification of malignant tumor type does not typically change emergency care *Majority of tumors encompassed by<ref>DeAngelis LM. Brain tumors. N Engl J Med...") |
ClaireLewis (talk | contribs) No edit summary |
||
| (12 intermediate revisions by 4 users not shown) | |||
| Line 9: | Line 9: | ||
==Clinical Features== | ==Clinical Features== | ||
*Maintain high index of clinical suspicion | |||
*Cerebral edema in itself does not produce neuro findings until ICP elevation causes ischemia<ref>Pollay M. Blood-Brain Barrier, Cerebral Edema. In : Wilkins RH, Rengachary SS, editors. Neurosurgery. 2nd ed. New York: Mc Graw Hill Book Co., 1996;335-44.</ref> | |||
*Findings: | |||
**[[Altered mental status]] | |||
**Extremity [[numbness|sensory]]/[[weakness|motor deficit]] | |||
**[[Bradycardia]], [[hypertension|elevated BP]], irregular breathing | |||
**EOM abnormalities | |||
**Pupillary size abnormalities | |||
**Extensor plantar response | |||
**See also: [[Herniation Syndromes]] | |||
==[[Corticosteroids]]== | |||
*Reduce tumor capillary permeability, inflammatory cytotoxicity | |||
*[[Dexamethasone]] IV bolus 10-20mg on initial presentation<ref>Nahaczewski AE et al. Dexamethasone Therapy in Patients With Brain Tumors - A Focus on Tapering. J Neurosci Nurs. 2004;36(6):340-343.</ref> | |||
**Followed by 4mg IV q6hrs | |||
**PO and IV dosing equivalent bioavailability | |||
**May see improvement within 12-48hrs | |||
*Complications<ref>Dietric J et al. Corticosteroids in brain cancer patients: benefits and pitfalls. Expert Rev Clin Pharmacol. 2011 Mar; 4(2): 233–242.</ref>: | |||
**[[GI bleed]]s - ensure GI prophylaxis | |||
**Osteoporosis - avoid in pathologic [[fracture]] | |||
**Neuropsychiatric - avoid in acute [[psychosis]] | |||
**Steroid myopathy - consider nonfluorinated steroids, such as [[prednisone]], over dexamethasone | |||
== | ==See Also== | ||
*[[Elevated intracranial pressure]] | |||
*[[Corticosteroids]] | |||
*[[Brain tumor]] | |||
==References== | |||
<references/> | <references/> | ||
[[Category:Neurology]] | |||
[[Category:Heme/Onc]] | |||
Latest revision as of 00:07, 1 October 2019
Background
- Classification of malignant tumor type does not typically change emergency care
- Majority of tumors encompassed by[1]:
- Metastasis
- Gliomas
- Meningiomas
- Pituitary adenomas
- Acoustic neuromas
Clinical Features
- Maintain high index of clinical suspicion
- Cerebral edema in itself does not produce neuro findings until ICP elevation causes ischemia[2]
- Findings:
- Altered mental status
- Extremity sensory/motor deficit
- Bradycardia, elevated BP, irregular breathing
- EOM abnormalities
- Pupillary size abnormalities
- Extensor plantar response
- See also: Herniation Syndromes
Corticosteroids
- Reduce tumor capillary permeability, inflammatory cytotoxicity
- Dexamethasone IV bolus 10-20mg on initial presentation[3]
- Followed by 4mg IV q6hrs
- PO and IV dosing equivalent bioavailability
- May see improvement within 12-48hrs
- Complications[4]:
- GI bleeds - ensure GI prophylaxis
- Osteoporosis - avoid in pathologic fracture
- Neuropsychiatric - avoid in acute psychosis
- Steroid myopathy - consider nonfluorinated steroids, such as prednisone, over dexamethasone
See Also
References
- ↑ DeAngelis LM. Brain tumors. N Engl J Med. 2001 Jan 11. 344(2):114-23.
- ↑ Pollay M. Blood-Brain Barrier, Cerebral Edema. In : Wilkins RH, Rengachary SS, editors. Neurosurgery. 2nd ed. New York: Mc Graw Hill Book Co., 1996;335-44.
- ↑ Nahaczewski AE et al. Dexamethasone Therapy in Patients With Brain Tumors - A Focus on Tapering. J Neurosci Nurs. 2004;36(6):340-343.
- ↑ Dietric J et al. Corticosteroids in brain cancer patients: benefits and pitfalls. Expert Rev Clin Pharmacol. 2011 Mar; 4(2): 233–242.